Related Experiment Video

Updated: Aug 19, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos

K Okazaki1, N Sagata

  • 1Division of Molecular Genetics, Kurume University, Fukuoka, Japan.

Oncogene
|March 16, 1995
PubMed

Insights

The Mos proto-oncogene activates the Mek1/MAPK pathway, driving cell transformation. Inhibiting this pathway with dominant-negative Mek1 suppressed Mos-induced transformation, confirming its essential role.

Area of Science:

  • Oncogenic signaling pathways
  • Cell cycle regulation
  • Molecular oncology

Background:

  • The Mos proto-oncogene product is a serine/threonine kinase crucial for vertebrate oocyte meiotic cell cycle control.
  • Mitogen-activated protein kinase (MAPK) pathway activation is observed in cells transformed by various oncogenes, suggesting its role in oncogenic signaling.
  • Mos activates MAPK, likely through direct phosphorylation of MAPK kinase (MAPKK).

Purpose of the Study:

  • To investigate whether MAPK pathway activation mediates oncogenic transformation induced by Mos.
  • To determine the necessity and sufficiency of the Mek1/MAPK pathway in Mos-mediated NIH3T3 cell transformation.

Main Methods:

  • Utilized mouse NIH3T3 cells for transformation assays.
  • Employed co-expression of kinase-defective (dominant-negative) and wild-type Mek1 mutants.
  • Assessed the effect of Mek1 modulation on Mos-induced transformation phenotype and maintenance.

Main Results:

  • Co-expression of dominant-negative Mek1 completely suppressed Mos-induced transformation.
  • Wild-type Mek1 significantly enhanced Mos's transforming efficiency.
  • Overexpression of dominant-negative Mek1 reverted the transformed phenotype in Mos-transformed cells.
  • Dominant-negative Mek1 also suppressed Raf- and Ras-induced transformation, but less effectively than Mos-induced transformation.

Conclusions:

  • The Mek1/MAPK pathway is both necessary and sufficient for the initiation and maintenance of oncogenic transformation by Mos in NIH3T3 cells.
  • Mos-induced transformation is critically dependent on the Mek1/MAPK pathway.
  • Raf and Ras oncoproteins may utilize multiple signaling pathways, unlike Mos, which appears more specifically reliant on Mek1/MAPK.

More Related Videos

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...